Modeling complete removal of risk assessment questions in the USA predicts the risk of HIV exposure in blood recipients could increase despite the use of nucleic acid testing
- 14 January 2016
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 110 (4), 324-328
- https://doi.org/10.1111/vox.12375
Abstract
Background and Objectives The safety of the blood supply in a number of countries is achieved by interventions that include behaviour‐based time‐limited or indefinite deferrals and screening of donated units for transfusion‐transmitted infections. The relatively high sensitivity of nucleic acid testing (NAT) used in blood donor screening has raised the question of whether such time‐based deferrals can be eliminated in favour of individual risk assessment. Materials and Methods Data on the annual number of incident human immunodeficiency virus (HIV) infections associated with various behaviours and on the performance characteristics of NAT applied to donor screening were used to model the number of potentially infected units that might escape detection in the worst‐case scenario in which individual risk assessment was implemented, but was not effective as a screening tool, and donors did not otherwise self‐select for lower risk. Results In the absence of effective individual risk‐based screening or donor self‐selection, the model predicts that in the United States, an additional 39 (95% CI 35–43) HIV‐infected units would escape detection by nucleic acid testing, potentially capable of exposing approximately 68 (95% CI 61–75) individuals to the risk of HIV infection through the administration of prepared blood components. Conclusion Despite some inherent uncertainty, the worst‐case scenario of completely ineffective individual risk assessment, absence of donor self‐selection and increased reliance on NAT for blood screening is estimated to be associated with an approximately fourfold increase in the risk of HIV exposure through transfusion in the United States.Keywords
Funding Information
- Center for Biologics Evaluation and Research of the United States Food and Drug Administration
This publication has 10 references indexed in Scilit:
- Blood donor deferral for men who have sex with men: the Blood Donation Rules Opinion Study (Blood DROPS)Transfusion, 2015
- Risk factors for retrovirus and hepatitis virus infections in accepted blood donorsTransfusion, 2014
- Understanding noncompliance with selective donor deferral criteria for high‐risk behaviors in Australian blood donorsTransfusion, 2014
- Three decades of MSM donor deferral policies. What have we learned?International Journal of Infectious Diseases, 2014
- Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year reviewVox Sanguinis, 2012
- Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic DonationsTransfusion Medicine Reviews, 2012
- No evidence of a significantly increased risk of transfusion‐transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12‐month deferral for men who have had sex with men (CME)Transfusion, 2010
- Transfusion‐associated infections: 50 years of relentless challenges and remarkable progressTransfusion, 2010
- Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infectionTransfusion, 2005
- The acute retroviral syndrome and the pathogenesis of HIV-1 infectionSeminars in Immunology, 1993